AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 53 of 93

54 Specific Conditions 4.3.1. Ebstein Anomaly COR LOE Recommendations 2b B-NR 9. In adults with Ebstein anomaly and severe RV dysfunction in whom there is concern that the RV will not tolerate supporting the entire stroke volume, a bidirectional superior cavopulmonary (Glenn) anastomosis at the time of tricuspid valve surgery may be considered in carefully selected individuals to improve cardiac output through ventricular unloading. 2b C-LD 10. In adults with Ebstein anomaly who have an ASD/patent foramen ovale, and cyanosis or paradoxical embolism, isolated closure may be considered after hemodynamic assessment to improve clinical outcomes. (cont'd) Table 26. Ebstein Anomaly: Routine Follow-Up and Testing Intervals Type of Follow-Up or Testing Physiological Stage A* (mo) Physiological Stage B* (mo) Physiological Stage C* (mo) Physiological Stage D* (mo) Outpatient ACHD cardiologist 12–24 12 6–12 3–6 Electrocardiogram 12–24 12 12 12 Transthoracic echocardiogram † 12–24 12–24 12 12 For recommendations about timing of CMR imaging, see Section 4.3.1 supportive text for recommendation #2. Modified with permission from Stout et al. Copyright © 2018 American Heart Association, Inc. and American College of Cardiolog y Foundation. * See Section 2.2 for details on the ACHD anatomic and physiological classification system. † Routine transthoracic echocardiogram may be unnecessary in a year when CMR imaging is performed, unless clinical indications warrant otherwise. ACHD indicates adult congenital heart disease; and CMR, cardiovascular magnetic resonance.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease